IS4183A - Hliðstæð aðferð við að framleiða nýjar (1-fenýl-1-heterósýklýl)alkanafleiður og notkun þeirra við að vernda taugar - Google Patents

Hliðstæð aðferð við að framleiða nýjar (1-fenýl-1-heterósýklýl)alkanafleiður og notkun þeirra við að vernda taugar

Info

Publication number
IS4183A
IS4183A IS4183A IS4183A IS4183A IS 4183 A IS4183 A IS 4183A IS 4183 A IS4183 A IS 4183A IS 4183 A IS4183 A IS 4183A IS 4183 A IS4183 A IS 4183A
Authority
IS
Iceland
Prior art keywords
heterocyclyl
phenyl
analogous method
producing novel
alkane derivatives
Prior art date
Application number
IS4183A
Other languages
English (en)
Other versions
IS1742B (is
Inventor
Robin Boar Bernard
John Cross Alan
Alastair Gray Duncan
Richard Green Alfred
Original Assignee
Ab Astra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ab Astra filed Critical Ab Astra
Publication of IS4183A publication Critical patent/IS4183A/is
Publication of IS1742B publication Critical patent/IS1742B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IS4183A 1993-07-06 1994-06-23 Hliðstæð aðferð við að framleiða nýjar (1-fenýl-1-heterósýklýl)alkanafleiður og notkun þeirra við að vernda taugar IS1742B (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE19939302333A SE9302333D0 (sv) 1993-07-06 1993-07-06 New compounds

Publications (2)

Publication Number Publication Date
IS4183A true IS4183A (is) 1995-01-07
IS1742B IS1742B (is) 2000-02-21

Family

ID=20390540

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4183A IS1742B (is) 1993-07-06 1994-06-23 Hliðstæð aðferð við að framleiða nýjar (1-fenýl-1-heterósýklýl)alkanafleiður og notkun þeirra við að vernda taugar

Country Status (18)

Country Link
US (1) US5747515A (is)
EP (1) EP0707573A1 (is)
JP (1) JPH08512313A (is)
CN (1) CN1044705C (is)
AU (1) AU691191B2 (is)
BR (1) BR9406924A (is)
CA (1) CA2164876A1 (is)
CZ (1) CZ4196A3 (is)
FI (1) FI960077A0 (is)
HU (1) HUT74673A (is)
IS (1) IS1742B (is)
NO (1) NO305862B1 (is)
NZ (1) NZ268690A (is)
PL (1) PL179021B1 (is)
RU (1) RU2137763C1 (is)
SE (1) SE9302333D0 (is)
SK (1) SK281025B6 (is)
WO (1) WO1995001967A1 (is)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9726569D0 (en) * 1997-12-16 1998-02-11 Univ Southampton Neuroprotective agents
FR2774596B1 (fr) * 1998-02-11 2000-03-17 Rhone Poulenc Rorer Sa Utilisation de composes selenies dans la prevention et le traitement de la maladie d'alzheimer
CA2328973A1 (en) 1998-04-23 1999-10-28 Akio Ojida Naphthalene derivatives, their production and use
US6503935B1 (en) 1998-08-07 2003-01-07 Abbott Laboratories Imidazoles and related compounds as α1A agonists
US6156775A (en) * 1999-03-01 2000-12-05 Novartis Ag Use of fluorinated triazoles in treating affective and attention disorders
WO2000078727A1 (en) 1999-06-22 2000-12-28 Takeda Chemical Industries, Ltd. Process for the preparation of imidazole derivatives
SE9904177D0 (sv) * 1999-11-18 1999-11-18 Astra Ab Novel compounds
RU2275195C2 (ru) * 2003-06-19 2006-04-27 Наталья Борисовна Кармен Средство для защиты головного мозга от гипоксически-ишемического повреждения
AU2005229459B9 (en) * 2004-04-03 2009-01-22 Astrazeneca Ab Therapeutic agents
WO2008064317A1 (en) * 2006-11-22 2008-05-29 University Of Medicine And Dentistry Of New Jersey Lipophilic opioid receptor active compounds
JP2014525442A (ja) * 2011-08-30 2014-09-29 ヴィアメット ファーマスーティカルズ，インコーポレイテッド 金属酵素阻害化合物
CN104932538B (zh) * 2015-07-03 2018-02-23 中国计量科学研究院 光机旋转装置

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE121520C (is) *
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
US4649146A (en) * 1983-01-31 1987-03-10 Fujisawa Pharmaceutical Co., Ltd. Thiazole derivatives and pharmaceutical composition comprising the same
FR2625199B1 (fr) * 1987-12-23 1991-03-22 Irceba Derives oxyimino du thiazole, procede de preparation et utilisation en therapeutique
KR970010054B1 (ko) * 1987-12-29 1997-06-20 다이닛뽄 세이야꾸 가부시끼가이샤 허혈성 뇌장해 치료제
JPH01249760A (ja) * 1988-03-29 1989-10-05 Yamaha Corp ホトクロミック化合物
JPH0291076A (ja) * 1988-09-28 1990-03-30 Tokuyama Soda Co Ltd フォトクロミック性化合物及びその製造方法
GB8909737D0 (en) * 1989-04-27 1989-06-14 Shell Int Research Thiazole derivatives
TW224461B (is) * 1990-09-18 1994-06-01 Ciba Geigy Ag
US5177079A (en) * 1991-01-31 1993-01-05 Warner-Lambert Company 2-substituted-4,6-di-tertiarybutyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents
WO1992013844A1 (en) * 1991-01-31 1992-08-20 Warner-Lambert Company Substituted 4,6-di-tertiary-butyl-5-hydroxy-pyrimidines
GB9125924D0 (en) * 1991-06-18 1992-02-05 Orion Yhtymae Oy Stereoisomers of an imidazole derivative

Also Published As

Publication number Publication date
FI960077A7 (fi) 1996-01-08
SK159995A3 (en) 1996-06-05
NO960029D0 (no) 1996-01-04
CA2164876A1 (en) 1995-01-19
AU691191B2 (en) 1998-05-14
SK281025B6 (sk) 2000-11-07
CN1126990A (zh) 1996-07-17
CN1044705C (zh) 1999-08-18
FI960077A0 (fi) 1996-01-08
SE9302333D0 (sv) 1993-07-06
RU2137763C1 (ru) 1999-09-20
HUT74673A (en) 1997-01-28
PL179021B1 (pl) 2000-07-31
JPH08512313A (ja) 1996-12-24
NO960029L (no) 1996-01-04
US5747515A (en) 1998-05-05
IS1742B (is) 2000-02-21
CZ4196A3 (en) 1996-06-12
PL312427A1 (en) 1996-04-29
NZ268690A (en) 1997-11-24
NO305862B1 (no) 1999-08-09
HU9503742D0 (en) 1996-02-28
WO1995001967A1 (en) 1995-01-19
AU7197894A (en) 1995-02-06
EP0707573A1 (en) 1996-04-24
BR9406924A (pt) 1996-07-30

Similar Documents

Publication Publication Date Title
PL315174A1 (en) Novel derivatives of gingolydes and method of obtaining them
NO954690D0 (no) Intelligent akkompagnementsapparat og fremgangsmåte
PL305543A1 (en) Derivatives of 1-amino ethylindole, method of obtaining them and therapeutic agents containming such derivatives
KR960701252A (ko) 스티치접합된 물품 및 그 제조 방법(stitchbonded articles and method of making same)
IS4622A (is) Sjóntækjabúnaður og aðferð
NO180651C (no) Fremgangsmåte og anordning for utförelse av brönn-perforering
NO981108L (no) Freseapparat og fremgangsmÕte ved fresing
SG55106A1 (en) Character generating apparatus and method of the same
NO933500L (no) Monteringsverktöy og relatert fremgangsmåte
IS3792A7 (is) Benzodiazepinones og aðferð til framleiðslu þess
IS4183A (is) Hliðstæð aðferð við að framleiða nýjar (1-fenýl-1-heterósýklýl)alkanafleiður og notkun þeirra við að vernda taugar
DK110791D0 (da) Fremgangsmaade og anvendelse af porphyriner
DK223089D0 (da) Lysdaemper og fremgangsmaade til fremstilling deraf
IS4182A (is) Nýjar (1-heteróasólýl-1-heterósýklýl) alkanafleiður og notkun þeirra við að vernda taugar
FI91240B (fi) Menetelmä hapen ja/tai otsonin valmistamiseksi
UA10998C2 (uk) Спосіб поліфакторhої лікувальhої дії та ковдра для поліфакторhої лікувальhої дії
FI941414L (fi) Menetelmä ja laitteisto bioproteiinien valmistamiseksi
DK0641978T3 (da) Kølefremgangsmåde og -apparat
DE69418687D1 (de) Mustererzeugungsgerät und Mustererzeugungsmethode
FI896044A7 (fi) Tuotantolinjamenetelmä ja -laite ohjeiden tehokasta toimeenpanoa varten
FI942810A0 (fi) Tupakanlaajennusmenetelmä ja -laite
AU6515490A (en) Coronary thrombectomy apparatus and method of use
PL305757A1 (en) Fluorinated derivatives of 4-amino androstadienone and method of obtaining them
DK3191D0 (da) Flydende line og fremgangsmaade til fremstilling deraf
ITRM940763A0 (it) Disposizione e metodo di sintesi vocale